AB2 Bio Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20.6M

  • Investors
  • 2

AB2 Bio General Information

Description

Developer of therapies designed for the treatment of inflammatory diseases. The company develops treatments and medicines for inflammatory and autoimmune diseases with unmet medical needs, enabling medical practitioners to not only treat the symptoms but also target the underlying causes of inflammation-based diseases.

Contact Information

Website
www.ab2bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • EPFL Innovation Park
  • Building B, 4th Floor
  • 1015 Lausanne
  • Switzerland
+41 021 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AB2 Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Feb-2023 $20.6M 000.00 Completed Clinical Trials - Phase 3
2. Later Stage VC (Series B) 14-Jan-2016 000.00 000.00 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view AB2 Bio’s complete valuation and funding history, request access »

AB2 Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapies designed for the treatment of inflammatory diseases. The company develops treatments and medicine
Drug Discovery
Lausanne, Switzerland
000.00
0000000000 0 000.00

000000

mpor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Amsterdam, Netherlands
00 As of 0000
000.00
0000000000 0 000.00

000000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AB2 Bio Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Calypso Biotech Venture Capital-Backed Amsterdam, Netherlands 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000000 Corporate Backed or Acquired Basel, Switzerland 000000&0
000000000 Venture Capital-Backed Hennigsdorf, Germany 00 000.00 0000000000 0 000.00
0000 000000000000 Venture Capital-Backed Oxford, United Kingdom 000 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

AB2 Bio Patents

  • 30

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

AB2 Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021312347-A1 Avoiding or minimizing side-effects related to car-t-cell therapy Pending 24-Jul-2020 0000000000
CA-3185868-A1 Avoiding or minimizing side-effects related to car-t-cell therapy Pending 24-Jul-2020 0000000000
US-20220401476-A1 Car-t-cell therapy Pending 24-Jul-2020 0000000000
EP-3943097-A1 Car-t cell therapy Pending 24-Jul-2020 000000000 00
EP-4185313-A1 Avoiding or minimizing side-effects related to car-t-cell therapy Pending 24-Jul-2020 A61K35/17
To view AB2 Bio’s complete patent history, request access »

AB2 Bio Executive Team (7)

Name Title Board Seat Contact Info
Djordje Filipovic Ph.D Chief Executive Officer
Fernando Cunha Chief Financial Officer
Barthélemy Helg Co-Founder & Board Member
Erich Hunziker Ph.D Chairman
You’re viewing 4 of 7 executive team members. Get the full list »

AB2 Bio Board Members (8)

Name Representing Role Since
Adriano Aguzzi MD Self Board Member 000 0000
Andrea Pfeifer Ph.D Self Chairwoman 000 0000
Barthélemy Helg AB2 Bio Co-Founder & Board Member 000 0000
Bénédict Hentsch AB2 Bio Board Member 000 0000
Diego Braguglia Ph.D VI Partners Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

AB2 Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
VI Partners Venture Capital Minority 000 0000 000000 0
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0
To view AB2 Bio’s complete investors history, request access »

Ready to get started?

Request a free trial